Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer Inc Cancer Drug Ibrance’s Prospects Boosted by Positive Phase 3 Data
Pfizer Inc Cancer Drug Ibrance’s Prospects Boosted by Positive Phase 3 Data
Pfizer Inc Cancer Drug Ibrance’s Prospects Boosted by Positive Phase 3 Data
Submitted by
admin
on April 20, 2016 - 12:40pm
Source:
Bidness, ETC
News Tags:
Pfizer
Ibrance
breast cancer
clinical trials
Headline:
Pfizer Inc Cancer Drug Ibrance’s Prospects Boosted by Positive Phase 3 Data
Do Not Allow Advertisers to Use My Personal information
